These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 11790270

  • 21. Hormone replacement therapy (HRT) and ischaemic heart disease: getting to the heart of the matter.
    Chew S, Ng SC.
    Singapore Med J; 2002 Jan; 43(1):41-4. PubMed ID: 12008777
    [Abstract] [Full Text] [Related]

  • 22. Hormone replacement therapy for prevention of coronary heart disease: current evidence.
    Khurana PS, Khurana C, Hsia J.
    Curr Atheroscler Rep; 2001 Sep; 3(5):399-403. PubMed ID: 11487451
    [Abstract] [Full Text] [Related]

  • 23. Long-term consequences of estrogen and estrogen-progestin replacement.
    Adami HO.
    Cancer Causes Control; 1992 Jan; 3(1):83-90. PubMed ID: 1536919
    [Abstract] [Full Text] [Related]

  • 24. Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease.
    Herrington DM, Werbel BL, Riley WA, Pusser BE, Morgan TM.
    J Am Coll Cardiol; 1999 Jun; 33(7):2030-7. PubMed ID: 10362210
    [Abstract] [Full Text] [Related]

  • 25. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
    Clanget C, Hinke V, Lange S, Fricke R, Botko R, Pfeilschifter J.
    Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155
    [Abstract] [Full Text] [Related]

  • 26. Cardiovascular implications of estrogen replacement therapy.
    Lobo RA.
    Obstet Gynecol; 1990 Apr; 75(4 Suppl):18S-25S; discussion 31S-35S. PubMed ID: 2179786
    [Abstract] [Full Text] [Related]

  • 27. Preserving cardiovascular benefits of hormone replacement therapy.
    Bush TL.
    J Reprod Med; 2000 Mar; 45(3 Suppl):259-73. PubMed ID: 10756507
    [Abstract] [Full Text] [Related]

  • 28. The role of progestins in hormone replacement therapy.
    Lobo RA.
    Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 2):1997-2004. PubMed ID: 1605291
    [Abstract] [Full Text] [Related]

  • 29. Three-year study of estrogen alone versus combined with progestin in postmenopausal women with or without hypercholesterolemia.
    Sanada M, Nakagawa H, Kodama I, Sakasita T, Ohama K.
    Metabolism; 2000 Jun; 49(6):784-9. PubMed ID: 10877207
    [Abstract] [Full Text] [Related]

  • 30. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.
    Mohandas B, Mehta JL.
    Curr Opin Cardiol; 2007 Sep; 22(5):434-42. PubMed ID: 17762545
    [Abstract] [Full Text] [Related]

  • 31. Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS).
    Simon JA, Hsia J, Cauley JA, Richards C, Harris F, Fong J, Barrett-Connor E, Hulley SB.
    Circulation; 2001 Feb 06; 103(5):638-42. PubMed ID: 11156873
    [Abstract] [Full Text] [Related]

  • 32. How progestins influence the cardiovascular effect of hormone replacement therapy.
    Rosano GM, Mercuro G, Vitale C, Rossini P, Galetta P, Fini M.
    Gynecol Endocrinol; 2001 Dec 06; 15 Suppl 6():9-17. PubMed ID: 12227881
    [Abstract] [Full Text] [Related]

  • 33. Cardiovascular disease in women and noncontraceptive use of hormones: a feminist analysis.
    MacPherson KI.
    ANS Adv Nurs Sci; 1992 Jun 06; 14(4):34-49. PubMed ID: 1605587
    [Abstract] [Full Text] [Related]

  • 34. Effects of estrogens on lipoprotein metabolism and cardiovascular disease in women.
    Knopp RH, Zhu X, Bonet B.
    Atherosclerosis; 1994 Oct 06; 110 Suppl():S83-91. PubMed ID: 7857390
    [Abstract] [Full Text] [Related]

  • 35. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM, Maffei S, Andreassi MG, Vitale C, Vassalle C, Gambacciani M, Stramba-Badiale M, Mercuro G.
    J Cardiovasc Med (Hagerstown); 2009 Jan 06; 10(1):85-92. PubMed ID: 19145119
    [Abstract] [Full Text] [Related]

  • 36. Postmenopausal hormone replacement therapy: does the progestin make a difference?
    Fylstra DL.
    J S C Med Assoc; 2002 Feb 06; 98(1):12-9. PubMed ID: 11859600
    [No Abstract] [Full Text] [Related]

  • 37. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
    Gambrell RD.
    Fertil Steril; 1982 Apr 06; 37(4):457-74. PubMed ID: 7040116
    [Abstract] [Full Text] [Related]

  • 38. Postmenopausal hormone replacement therapy--clinical implications.
    Ravn SH, Rosenberg J, Bostofte E.
    Eur J Obstet Gynecol Reprod Biol; 1994 Feb 06; 53(2):81-93. PubMed ID: 8194655
    [Abstract] [Full Text] [Related]

  • 39. Estrogen plus progestin therapy: the cardiovascular risks exceed the benefits.
    Penckofer SM, Hackbarth D, Schwertz DW.
    J Cardiovasc Nurs; 2003 Feb 06; 18(5):347-55. PubMed ID: 14680337
    [Abstract] [Full Text] [Related]

  • 40. A review of the association of estrogens and progestins with cardiovascular disease in postmenopausal women.
    Psaty BM, Heckbert SR, Atkins D, Siscovick DS, Koepsell TD, Wahl PW, Longstreth WT, Weiss NS, Wagner EH, Prentice R.
    Arch Intern Med; 1993 Jun 28; 153(12):1421-7. PubMed ID: 8512434
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.